Novartis AG
Patents, Design & Utilities

Last updated:

List of all Novartis AG patents 1,223 in total

Status Patent
Grant
Utility: Stable protein solution formulation containing high concentration of an anti-VEGF antibody External link
Filling date: 23 Sep 2025 Issue date: 23 Jun 2020
Application
Utility: NOVEL 3' END CAPS, 5' END CAPS AND COMBINATIONS THEREOF FOR THERAPEUTIC RNA External link
Filling date: 23 Sep 2025 Issue date: 18 Jun 2020
Application
Utility: PROTEIN SOLUTION FORMULATION CONTAINING HIGH CONCENTRATION OF AN ANTI-VEGF ANTIBODY External link
Filling date: 23 Sep 2025 Issue date: 18 Jun 2020
Application
Utility: POLYOMAVIRUS NEUTRALIZING ANTIBODIES External link
Filling date: 23 Sep 2025 Issue date: 18 Jun 2020
Application
Utility: FILLING ADAPTER AND INJECTION SOLUTION TRANSFERRING SYSTEM External link
Filling date: 23 Sep 2025 Issue date: 18 Jun 2020
Application
Utility: INJECTION DEVICE AND INJECTION SOLUTION TRANSFERRING SYSTEM External link
Filling date: 23 Sep 2025 Issue date: 18 Jun 2020
Application
Utility: CRYSTALLINE FORMS OF 4-(2-((1R,2R)-2-HYDROXYCYCLOHEXYLAMINO)BENZOTHIAZOL-6-YLOXY)-N-METHYLPICO- LINAMIDE External link
Filling date: 23 Sep 2025 Issue date: 18 Jun 2020
Grant
Utility: Heterocyclic derivatives and their use in the treatment of neurological disorders External link
Filling date: 23 Sep 2025 Issue date: 16 Jun 2020
Grant
Utility: Compositions and methods for modulating farnesoid X receptors External link
Filling date: 23 Sep 2025 Issue date: 16 Jun 2020
Grant
Utility: Anti-IL-17A antibodies and their use in treating autoimmune and inflammatory disorders External link
Filling date: 23 Sep 2025 Issue date: 16 Jun 2020
Grant
Utility: Compositions and methods for antibodies targeting BMP6 External link
Filling date: 23 Sep 2025 Issue date: 16 Jun 2020
Grant
Utility: Composite actuation handles for a surgical instrument External link
Filling date: 23 Sep 2025 Issue date: 16 Jun 2020
Application
Utility: SYRINGE External link
Filling date: 23 Sep 2025 Issue date: 11 Jun 2020
Application
Utility: COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES External link
Filling date: 23 Sep 2025 Issue date: 11 Jun 2020
Application
Utility: METHODS OF SELECTIVELY TREATING ASTHMA USING IL-13 ANTAGONISTS External link
Filling date: 23 Sep 2025 Issue date: 11 Jun 2020
Application
Utility: OCULAR IMPLANT WITH STIFFNESS QUALITIES, METHODS OF IMPLANTATION AND SYSTEM External link
Filling date: 23 Sep 2025 Issue date: 11 Jun 2020
Application
Utility: HSA-GDF-15 FUSION POLYPEPTIDE AND USE THEREOF External link
Filling date: 23 Sep 2025 Issue date: 11 Jun 2020
Application
Utility: N-AZASPIROCYCLOALKANE SUBSTITUTED N-HETEROARYL COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2 External link
Filling date: 23 Sep 2025 Issue date: 11 Jun 2020
Application
Utility: METHODS FOR PREVENTING AND TREATING URINARY INCONTINENCE External link
Filling date: 23 Sep 2025 Issue date: 11 Jun 2020
Application
Utility: BISPECIFIC ANTIBODIES THAT BIND CD 123 CD3 External link
Filling date: 23 Sep 2025 Issue date: 11 Jun 2020
Application
Utility: BCMA-TARGETING AGENT, AND COMBINATION THERAPY WITH A GAMMA SECRETASE INHIBITOR External link
Filling date: 23 Sep 2025 Issue date: 11 Jun 2020
Grant
Utility: Polymerizable polysiloxanes with hydrophilic substituents External link
Filling date: 23 Sep 2025 Issue date: 9 Jun 2020
Grant
Utility: Phosphorylcholine-containing poly(meth)acrylamide-based copolymers External link
Filling date: 23 Sep 2025 Issue date: 9 Jun 2020
Grant
Utility: Methods of selectively treating asthma using IL-17 antagonists External link
Filling date: 23 Sep 2025 Issue date: 9 Jun 2020
Grant
Utility: Membrane delamination devices External link
Filling date: 23 Sep 2025 Issue date: 9 Jun 2020
Grant
Utility: Imidazolepyridine compounds and uses thereof External link
Filling date: 23 Sep 2025 Issue date: 9 Jun 2020
Grant
Utility: Multifocal lens having reduced visual disturbances External link
Filling date: 23 Sep 2025 Issue date: 9 Jun 2020
Grant
Utility: 3' end caps, 5' end caps and combinations thereof for therapeutic RNA External link
Filling date: 23 Sep 2025 Issue date: 9 Jun 2020
Application
Utility: STABLE AND SOLUBLE ANTIBODIES INHIBITING VEGF External link
Filling date: 23 Sep 2025 Issue date: 4 Jun 2020
Application
Utility: METHODS OF TREATING PSORIASIS USING IL-17 ANTAGONISTS External link
Filling date: 23 Sep 2025 Issue date: 4 Jun 2020
Application
Utility: THERAPEUTIC REGIMEN External link
Filling date: 23 Sep 2025 Issue date: 4 Jun 2020
Application
Utility: DOSAGE REGIMENS OF ANTI-LAG-3 ANTIBODIES AND USES THEREOF External link
Filling date: 23 Sep 2025 Issue date: 4 Jun 2020
Application
Utility: ANTIBODY MOLECULES TO CD73 AND USES THEREOF External link
Filling date: 23 Sep 2025 Issue date: 4 Jun 2020
Grant
Utility: Substituted bisphenyl butanoic ester derivatives as NEP inhibitors External link
Filling date: 23 Sep 2025 Issue date: 2 Jun 2020
Grant
Utility: Methods for making conjugates from disulfide-containing proteins External link
Filling date: 23 Sep 2025 Issue date: 2 Jun 2020
Grant
Utility: Optical fiber coupling reliability External link
Filling date: 23 Sep 2025 Issue date: 2 Jun 2020
Grant
Utility: Collapsible surgical mirror for intraocular visualization External link
Filling date: 23 Sep 2025 Issue date: 2 Jun 2020
Application
Utility: IMMUNOGLOBULIN FRAMEWORKS WHICH DEMONSTRATE ENHANCED STABILITY IN THE INTRACELLULAR ENVIRONMENT AND METHODS OF IDENTIFYING SAME External link
Filling date: 23 Sep 2025 Issue date: 28 May 2020
Application
Utility: CYCLIC TETRAMER COMPOUNDS AS PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) INHIBITORS FOR THE TREATMENT OF METABOLIC DISORDERS External link
Filling date: 23 Sep 2025 Issue date: 28 May 2020
Application
Utility: CRYSTALLINE FORMS OF 5-BROMO-2,6-DI(1H-PYRAZOL-1-YL)PYRIMIDIN-4-AMINE AND NEW SALTS External link
Filling date: 23 Sep 2025 Issue date: 28 May 2020
Application
Utility: ANTIBODY CONJUGATES COMPRISING TOLL-LIKE RECEPTOR AGONIST AND COMBINATION THERAPIES External link
Filling date: 23 Sep 2025 Issue date: 28 May 2020
Grant
Utility: Compounds and compositions for inducing chondrogenesis External link
Filling date: 23 Sep 2025 Issue date: 26 May 2020
Grant
Utility: Aminoheteroaryl benzamides as kinase inhibitors External link
Filling date: 23 Sep 2025 Issue date: 26 May 2020
Grant
Utility: Apparatus for sealing an ophthalmic lens package External link
Filling date: 23 Sep 2025 Issue date: 26 May 2020
Grant
Utility: Directed differentiation of oligodendrocyte precursor cells to a myelinating cell fate External link
Filling date: 23 Sep 2025 Issue date: 26 May 2020
Grant
Utility: Casting mold for the manufacture of ophthalmic lenses External link
Filling date: 23 Sep 2025 Issue date: 26 May 2020
Grant
Utility: Compositions and methods of use for augmented immune response and cancer therapy External link
Filling date: 23 Sep 2025 Issue date: 26 May 2020
Application
Utility: SILICONE HYDROGEL LENS WITH A CROSSLINKED HYDROPHILIC COATING External link
Filling date: 23 Sep 2025 Issue date: 21 May 2020
Application
Utility: THERAPEUTIC COMBINATION OF A THIRD GENERATION EGFR TYROSINE KINASE INHIBITOR AND A CYCLIN D KINASE INHIBITOR External link
Filling date: 23 Sep 2025 Issue date: 21 May 2020
Grant
Utility: Method and device for cleaning a molding surface of a reusable lens mold External link
Filling date: 23 Sep 2025 Issue date: 19 May 2020

Showing 800 to 850 of 1223 patents.